Geriatric Head Trauma Short Term Outcomes Project (GREAT-STOP)

July 31, 2022 updated by: Florida Atlantic University
This prospective observational study will examine the incidence of intracranial hemorrhage. The investigators will compare patients on anticoagulant and/or antiplatelet therapy with head trauma compared to patients not on these medications. While many studies have sought to quantify the incidence of intracranial hemorrhage in these patients, there is considerable controversy regarding their care and what to do after an initial negative head CT in anticoagulated geriatric patients who have experienced head trauma.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

5387

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Delray Beach, Florida, United States, 33484
        • Delray Medical Center
      • West Palm Beach, Florida, United States, 33407
        • St. Mary's Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The Delray Medical Center and St. Mary's Medical Center emergency departments will be the major focal points for the study. These medical centers are located in Palm Beach County, Florida. Florida has the highest percentage of geriatric patients in the United States and, in particular, Palm Beach County has over 250,000 residents over the age of 65.

Description

Inclusion Criteria: Patients seen in the emergency department for head trauma

Exclusion Criteria: Penetrating head trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with 14 Day ED Returns
Time Frame: 14 days
Return visit to ED within 2 weeks
14 days
Number of Participants with Primary Intracranial Hemorrhage
Time Frame: initial hospital visit
ICH on initial head CT scan
initial hospital visit
Number of Participants with Delayed Intracranial Hemorrhage
Time Frame: 14 days
ICH on repeat CT scan
14 days
Number of Participants with Hospitalizations at 14 days
Time Frame: 14 days
If patient is admitted for any reason after initial ED visit
14 days
Mortality of Participants
Time Frame: 60 days
Death of patient from any cause at primary visit or up to 60 days from follow-up
60 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
New Symptoms
Time Frame: 60 days
Any new symptoms
60 days
Life alterations
Time Frame: 60 days
Descriptive information from telephone interviews about how patients changed activities after head trauma
60 days
New interventions since fall
Time Frame: 60 days
Additional therapies or intervention instituted after minor head trauma
60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard Shih, MD, Florida Atlantic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2019

Primary Completion (Actual)

November 14, 2020

Study Completion (Actual)

November 14, 2020

Study Registration Dates

First Submitted

August 1, 2019

First Submitted That Met QC Criteria

August 1, 2019

First Posted (Actual)

August 5, 2019

Study Record Updates

Last Update Posted (Actual)

August 3, 2022

Last Update Submitted That Met QC Criteria

July 31, 2022

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 1326154

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall

3
Subscribe